| トルコ | オーストリア | スペイン | |
| 乳癌化学療法 | から $1,200 | から $15,000 | から $3,500 |
| ガンマナイフ | から $6,300 | から $32,000 | から $18,000 |
| アクチニウム225療法 | から $22,955 | から $55,000 | から $45,000 |
| 膠芽腫切除術 | から $14,400 | - | から $51,941 |
Javier Herrero Jover医師は、形成外科・再建外科のパイオニアであり、高度な3D手術計画を専門とする_doctor_1728_years_以上の経験を持つ専門家です。
ヨーロッパを代表する脳神経外科医であるOliver医師は、_doctor_255_years_'の経験を持ち、膠芽腫を含む脳腫瘍に対する低侵襲技術を専門としています。
Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.
Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.
Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.
She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.